Document is current

Article History

Received: 7 February 2026

Accepted: 21 May 2026

First Online: 12 June 2026

Declarations

:

: Elektra J Papadopoulos, Avijeet S Chopra, Kristina Fitzgerald, and Kavita Sail are employees of the funding company. Chad Gwaltney has received consulting fees from the funding company. Helen Doll, Amy Howerter, and Angela Stroupe have no relevant financial or non-financial interests to disclose. John Mascarenhas reports Research funding paid to my institution from Incyte, Abbvie, SOBI, Novartis, Geron, Kartos, Karyopharm, BMS, PharmaEssentia, DISC and consulting, advisory or DSMB fees from Incyte, Abbvie, SOBI, Novartis, Kartos, Geron, Karyopharm, GSK, BMS, Pfizer, Roche, Disc, PharmaEssentia, Italafarmacia, Keros amd Merck. Ruben Mesa reports Consultant (Honoraria) over past 3 years: Abbvie, Blueprint, BMS, CTI, Genentech, Geron, GSK, Incyte, Novartis, Sierra, Sierra Oncology, Telios and Research Support: Abbvie, Blueprint, BMS, CTI, Genentech, Incyte, Morphosys, Sierra.

: The study received ethics approval in the USA, Canada, and the UK. This study was performed in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All study documents were submitted and approved by Western Copernicus Group (IRB approval number 20204626). Participants confirmed their consent to participate and for their data to be included for study related publications.

: Informed consent was obtained from all individual participants included in the study.